glp 1 assay Eurofins Discovery Current Insights, Advantages and Challenges

Medicaid Services proposed to expand Medicare Part D and Medicaid to cover weight loss drugs

Evidence suggests GLP-1 therapies may modestly lower blood pressure while improving cardiometabolic risk in patients with diabetes and hypertension.

Its a hormone your gut naturally produces after you eat

Learn more about GPCR stock here.

Cardiovascular outcome trials (CVOTs) in people living with type 2 diabetes mellitus and obesity have confirmed the cardiovascular benefits of glucagon-like peptide 1 receptor agonists (GLP-1RAs), including reduced cardiovascular mortality, lower ...

Diabetes GLP-1s perform better but still leak demand: Diabetes-indicated GLP-1s show higher retention (24% at one year) and face fewer access hurdles due to broader coverage and disease framing, yet 76% of demand remains unmet